This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Title: Roger John Watson: Innovator in Herpes Simplex Virus Research
Introduction
Roger John Watson is a notable inventor based in the United States. He has made significant contributions to the field of virology, particularly in the study of Herpes Simplex Virus (HSV). His work focuses on the cloning and expression of HSV glycoprotein genes, which are crucial for developing vaccines.
Latest Patents
Roger John Watson holds 0 patents. However, he has developed a notable patent related to the production of herpes simplex viral proteins. The abstract of his disclosure outlines methods and compositions for cloning and expressing the HSV glycoprotein (gD) gene in single-cell host organisms. This innovative approach allows for the production of HSV-gene products that can be formulated as immunogens in vaccines to protect against HSV-1 and HSV-2 infections.
Career Highlights
Roger John Watson is associated with Molecular Genetics, Inc., where he applies his expertise in genetic engineering and virology. His research has the potential to impact vaccine development significantly, providing new avenues for combating herpes infections.
Collaborations
Throughout his career, Roger has collaborated with esteemed colleagues, including John Haynes Weis and Lynn William Enquist. These partnerships have fostered advancements in the understanding and treatment of viral infections.
Conclusion
Roger John Watson's contributions to herpes simplex virus research highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for future developments in vaccine technology.